Echo Therapeutics Inc (NASDAQ:ECTE)

1.40
Delayed Data
As of 3:08pm ET
 -0.03 / -2.10%
Today’s Change
0.39
Today|||52-Week Range
3.47
+3.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues19.1K19.1K19.1K0.00
 
 
 
 
Depreciation And Amortization99.9K98.9K97.9K96.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------96.0K
 
 
General Expenses2.6M3.8M2.8M2.7M
 
 
 
 
 
Research And Development1.1M1.7M1.2M613.4K
 
 
 
 
 
Total Operating Expenses2.7M3.9M2.9M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-3.9M-2.9M-2.8M
 
 
 
 
 
Extraordinary Credit140.0K393.0K473.0K--
 
 
 
 
Extraordinary Charge0.000.000.00-95.0K
 
 
Interest Expense On Debt243.2K243.8K3.1M0.00
 
 
 
 
Other Expenses0.001.5K0.00-2.6K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-3.8M-5.5M-2.9M
 
 
 
 
 
Income Taxes0.000.000.00-4.0K
 
 
Preferred Dividend0.000.000.00-350.0K
 
 
Net Income-2.8M-3.8M-5.5M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.9M12.1M12.7M12.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.9M12.1M12.7M12.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.31-$0.43-$0.26
 
 
 
 
 
EPS Diluted-$0.23-$0.31-$0.43-$0.26
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account